Novo Nordisk halts hiring as new CEO's restructuring continues — Negative

NVO   Proactive Investors — August 20, 2025

Novo Nordisk has initiated a hiring freeze as it looks to control costs under new boss Maziar Mike Doustdar. All markets and departments, apart from business-critical roles, will be affected by the pause, the company said.

image for news Novo Nordisk halts hiring as new CEO's restructuring continues

Shares of Palantir Technologies (NASDAQ:PLTR) plummeted 19.63% over the past five trading sessions, stalling a rally that has seen the stock gain 95.12% so far in 2025.

image for news Palantir Technologies (NASDAQ: PLTR) Stock Price Prediction for 2025: Where Will It Be in 1 Year

Ventas Stock Gains 15.5% Year to Date: Will It Continue to Rise? — Positive

VTR   Zacks Investment Research — August 20, 2025

VTR stock rallies 15.5% YTD as strong SHOP growth, accretive investments and a solid balance sheet fuel momentum.

image for news Ventas Stock Gains 15.5% Year to Date: Will It Continue to Rise?

Down 31.9% in 4 Weeks, Here's Why Enovix Corporation (ENVX) Looks Ripe for a Turnaround — Positive

ENVX   Zacks Investment Research — August 20, 2025

Enovix Corporation (ENVX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

image for news Down 31.9% in 4 Weeks, Here's Why Enovix Corporation (ENVX) Looks Ripe for a Turnaround

The heavy selling pressure might have exhausted for Sagimet Biosciences Inc. (SGMT) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

image for news After Plunging 28% in 4 Weeks, Here's Why the Trend Might Reverse for Sagimet Biosciences Inc. (SGMT)

General Dynamics (GD) Just Overtook the 20-Day Moving Average — Positive

GD   Zacks Investment Research — August 20, 2025

After reaching an important support level, General Dynamics (GD) could be a good stock pick from a technical perspective. GD surpassed resistance at the 20-day moving average, suggesting a short-term bullish trend.

image for news General Dynamics (GD) Just Overtook the 20-Day Moving Average

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Lockheed Martin To Contact Him Directly To Discuss Their Options

image for news LMT Investors Have the Opportunity to Lead the Lockheed Martin Securities Fraud Lawsuit with Faruqi & Faruqi, LLP

Jiayin Group Inc. (JFIN) Q2 2025 Earnings Call Transcript — Neutral

JFIN   Seeking Alpha — August 20, 2025

Jiayin Group Inc. (NASDAQ:JFIN ) Q2 2025 Earnings Conference Call August 20, 2025 8:00 AM ET Company Participants Chunlin Fan - Chief Financial Officer Dinggui Yan - Founder, Chairman & CEO Yifang Xu - Chief Risk Officer & Director Conference Call Participants Yuxuan Chen - Huatai Securities Co., Ltd., Research Division Operator Good day, ladies and gentlemen.

image for news Jiayin Group Inc. (JFIN) Q2 2025 Earnings Call Transcript

2 Retail Stocks With Opposing Post-Earnings Reactions — Neutral

LOW  TGT   Schaeffers Research — August 20, 2025

Big-name retailers are filing into the earnings confessional this week, with investors keen to see how consumer spending is looking.

image for news 2 Retail Stocks With Opposing Post-Earnings Reactions

Why MSCI (MSCI) is a Top Stock for the Long-Term — Positive

MSCI   Zacks Investment Research — August 20, 2025

Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.

image for news Why MSCI (MSCI) is a Top Stock for the Long-Term

Estee Lauder (EL) Reports Q4 Earnings: What Key Metrics Have to Say — Positive

EL   Zacks Investment Research — August 20, 2025

Although the revenue and EPS for Estee Lauder (EL) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

image for news Estee Lauder (EL) Reports Q4 Earnings: What Key Metrics Have to Say

Wall Street Analysts See Celsius (CELH) as a Buy: Should You Invest? — Neutral

CELH   Zacks Investment Research — August 20, 2025

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

image for news Wall Street Analysts See Celsius (CELH) as a Buy: Should You Invest?

Target (TGT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates — Neutral

TGT   Zacks Investment Research — August 20, 2025

While the top- and bottom-line numbers for Target (TGT) give a sense of how the business performed in the quarter ended July 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

image for news Target (TGT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Wall Street Bulls Look Optimistic About M/I Homes (MHO): Should You Buy? — Neutral

MHO   Zacks Investment Research — August 20, 2025

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

image for news Wall Street Bulls Look Optimistic About M/I Homes (MHO): Should You Buy?

Wall Street Analysts Think Viking Therapeutics (VKTX) Is a Good Investment: Is It? — Positive

VKTX   Zacks Investment Research — August 20, 2025

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

image for news Wall Street Analysts Think Viking Therapeutics (VKTX) Is a Good Investment: Is It?

Analog Devices (ADI) Reports Q3 Earnings: What Key Metrics Have to Say — Positive

ADI   Zacks Investment Research — August 20, 2025

The headline numbers for Analog Devices (ADI) give insight into how the company performed in the quarter ended July 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

image for news Analog Devices (ADI) Reports Q3 Earnings: What Key Metrics Have to Say

Should You Invest in Abbott (ABT) Based on Bullish Wall Street Views? — Positive

ABT   Zacks Investment Research — August 20, 2025

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

image for news Should You Invest in Abbott (ABT) Based on Bullish Wall Street Views?

Is It Worth Investing in Humacyte, Inc. (HUMA) Based on Wall Street's Bullish Views? — Neutral

HUMA   Zacks Investment Research — August 20, 2025

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

image for news Is It Worth Investing in Humacyte, Inc. (HUMA) Based on Wall Street's Bullish Views?

Should You Invest in CVS Health (CVS) Based on Bullish Wall Street Views? — Positive

CVS   Zacks Investment Research — August 20, 2025

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

image for news Should You Invest in CVS Health (CVS) Based on Bullish Wall Street Views?

Wall Street Bulls Look Optimistic About Hercules Capital (HTGC): Should You Buy? — Positive

HTGC   Zacks Investment Research — August 20, 2025

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

image for news Wall Street Bulls Look Optimistic About Hercules Capital (HTGC): Should You Buy?